E-News ENews
2020, Issue 5 of 12 May 30, 2020 ncpharmacists.org
Advancing Pharmacy. Improving Health.
General News COVID-19: NC Moves to Phase 2 Opening Last Friday, North Carolina moved to a modified Phase 2 of an overall plan for emerging from the full stay at home Executive Order. After two weeks in Phase 1, the state’s overall key indicators remained stable, but the continued increases in daily case counts signaled a need to take a more modest step forward in Phase 2 than originally envisioned. Click here for an infographic showing what Phase 2 means as compared to the previous Phase 1 and Stay at Home Executive Orders. NCDHHS Launches Interactive COVID-19 Dashboard
Additional changes were made to NC DHHS COVID-19 dashboard to make it more interactive. The dashboard provides an overview on the metrics and capacities that the state is following to inform decisions necessary in responsibly addressing the virus in North Carolina. First Case of MIS-C Reported in North Carolina
While children generally experience mild symptoms with COVID-19, recently a possible link has been found between COVID-19 and multi-system inflammatory syndrome in some children (MIS-C) and teenagers who have current or recent infections. The first reports of this MIS-C came from the United Kingdom in late April. Cases in the United States were first reported in New York City in early May. NC DHHS has requested reporting of suspected cases of MIS-C from all health care providers. The state’s most recent COVID-19 Surveillance Report, updated May 21st, included the reporting of the first case of MIS-C in NC. This syndrome is a very rare condition, but as COVID-19 cases increase, additional reports of MIS-C could follow. MIS-C is not contagious, but because children with this syndrome may become seriously ill, it is important that parents and caregivers know the signs and symptoms their children may have so they can get help right away. Click here for helpful guidance you can provide to parents.
son for the Student Pharmacist Forum, and an advocacy update from Tony Solari, NCAP Lobbyist. Mr. Solari shared information about the passage of SB 704 and the expectations for movement on PBM legislation this session. A plan for addressing the collaborative practice bill was also reviewed, and a preview of the new NCAP advocacy website was provided to the Board. The Board also had a preview of a new association and learning management system for which funds were approved at the March 2020 Board meeting. President-elect Mills provided an update on increased Association communication efforts via social media; and the Board discussed new procedures for selecting delegates for APhA, and reporting processes for all delegations to national associations. The next NCAP Board of Directors meeting is scheduled for June 24th. NABP Compounding Pharmacy Accreditation Program
In January, the National Association of Boards of Pharmacy NCAP Board of Directors Met began offering its compounding on May 20th pharmacy accreditation program, which accompanies its existing This month’s Board of Directors inspection services, yielding a meeting included an introduction full-service option for compoundto Anita Yang, the new chairper- ing pharmacies. NABP was able
NCAP E-News Issue 5 of 12 Page 1